|
The role of the primary cilium in pancreatic ductal adenocarcinoma tumorigenesis
|
1F32CA150307-01
|
$45,590
|
$45,590
|
Abedin, Monika
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185 10318
|
$170,288
|
$170,288
|
Abnet, Christian
|
DCEG (NCI)
|
|
Risk factors for site-specific metastasis in esophageal cancer
|
5K07CA132892-03
|
$135,351
|
$135,351
|
Abrams, Julian
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Role of TLR4 in colitis-associated neoplasia
|
5R01CA137869-02
|
$317,475
|
$317,475
|
Abreu, Maria
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Regulation of Oncogene-Induced Senescence by Wnt-Signaling
|
5R01CA129334-03
|
$147,308
|
$51,558
|
ADAMS, PETER
|
UNIVERSITY OF GLASGOW
|
|
MRI for In Vivo Quantification of Yttrium-90 Microsphere Biodistribution
|
1F31CA150658-01
|
$31,692
|
$31,692
|
Adeyanju, Oyinlolu
|
NORTHWESTERN UNIVERSITY
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
3U54CA091408-10S1
|
$300,000
|
$90,000
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-10
|
$1,949,820
|
$584,946
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
Barriers to CRC in patients with mental illness.
|
5R03CA137825-02
|
$69,345
|
$69,345
|
AGGARWAL, ARPITA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
A MicroRNA Approach to Screen for Sporadic Colon Cancer Exfoliately in Human Stoo
|
1R43CA144823-01A1
|
$402,336
|
$402,336
|
Ahmed, Farid
|
GEM TOX CONSULTANTS AND LABS, INC.
|
|
Epigenetic markers involved in colorectal cancer recurrence and metastases
|
5K23CA127141-03
|
$140,940
|
$140,940
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Participation in the Eastern Cooperative Oncology Group
|
2U10CA107868-07
|
$235,766
|
$25,934
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha
|
1R01CA138671-01A1
|
$319,550
|
$319,550
|
Ajani, Jaffer
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Molecular Biomarkers as Classifiers to Individualize Therapy of Esophagus Cancer
|
5R21CA129906-02
|
$183,294
|
$183,294
|
Ajani, Jaffer
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Modeling causes and consequences of the evolution of cell motility in neoplasms
|
1F32CA144331-01
|
$50,474
|
$50,474
|
Aktipis, Christina
|
UNIVERSITY OF ARIZONA
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
$42,690
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-14
|
$1,182,811
|
$70,969
|
Albelda, Steven
|
UNIVERSITY OF PENNSYLVANIA
|
|
Amplicons in Oral Dysplasia
|
5R01CA131286-03
|
$270,000
|
$270,000
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Southeast Michigan Community Network Program
|
1U54CA153606-01
|
$796,611
|
$127,458
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-05S4
|
$24,999
|
$6,250
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-02
|
$584,016
|
$292,008
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
A web-based tailored health behavior intervention for African American colon canc
|
5R03CA138118-02
|
$74,000
|
$74,000
|
Allicock, Marlyn
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-11
|
$288,775
|
$72,194
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-02
|
$341,338
|
$58,027
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
|
7R21CA129302-02
|
$208,628
|
$208,628
|
Altomare, Deborah
|
UNIVERSITY OF CENTRAL FLORIDA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
$192,909
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Dietary Prevention of Cancer
|
3R01CA109269-07S1
|
$81,290
|
$81,290
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Dietary Prevention of Cancer
|
5R01CA109269-07
|
$283,480
|
$283,480
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
RNA Binding Proteins in Cancer
|
5R01CA135559-02
|
$303,988
|
$303,988
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Patterns of Patient Care in Appalachia
|
1R01CA140335-01A1
|
$458,946
|
$229,473
|
ANDERSON, ROGER
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
1R25CA153954-01
|
$335,580
|
$134,232
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183 00560
|
$113,406
|
$11,341
|
Anderson, William
|
DCEG (NCI)
|
|
Functions of Papillomavirus E6
|
2R01CA107394-06A2
|
$77,568
|
$51,971
|
ANDROPHY, ELLIOT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
|
5R01CA119904-03
|
$339,782
|
$115,526
|
ANDROPHY, ELLIOT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Functions of Papillomavirus E6
|
7R01CA107394-07
|
$252,560
|
$169,215
|
ANDROPHY, ELLIOT
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Mouse Models of Sporadic Colorectal Cancer
|
5K01CA128891-03
|
$107,687
|
$107,687
|
Angus-Hill, Melinda
|
UNIVERSITY OF UTAH
|
|
SBIR Topic 255: Evaluate Therapeutic Potential of Novel Immunomodulator, Imprime
|
N43CO100118-000
|
$159,140
|
$159,140
|
Antonysamy, Mary
|
BIOPOLYMER ENGINEERING, INC.:1183599
|
|
A New Method for Improved Targeting in Image-guided Abdominal Interventions
|
1R01CA138586-01A1
|
$369,350
|
$369,350
|
Archip, Neculai
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Southeast Cancer Control Consortium, Inc
|
2U10CA045808-24
|
$2,264,660
|
$339,699
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-12
|
$104,956
|
$11,545
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Vitamin D3 and Intestinal Tumorigenesis
|
1R21CA143570-01
|
$172,951
|
$172,951
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
MODULATION OF INTESTINAL HOMEOSTASIS AND CANCER
|
5R01CA135561-02
|
$322,596
|
$322,596
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
|
5R44CA121612-03
|
$685,832
|
$171,458
|
Aung, Sandra
|
UBIVAC, LLC
|
|
Eastern Cooperative Oncology Group Studies
|
2U10CA014548-36
|
$420,754
|
$46,283
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$99,147
|
$89,232
|
Avital, Itzhak
|
CCR (NCI)
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$198,294
|
$178,465
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$297,441
|
$237,953
|
Avital, Itzhak
|
CCR (NCI)
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
|
ZIA BC 011005
|
$198,294
|
$79,318
|
Avital, Itzhak
|
CCR (NCI)
|
|
Familial Gastric Cancer: Diagnosis, DNA Sequencing, Early detection
|
ZIA BC 011341
|
$99,147
|
$99,147
|
Avital, Itzhak
|
CCR (NCI)
|
|
Pancreatic perfusion for locally unresectable pancreatic cancer
|
ZIA BC 011342
|
$99,147
|
$99,147
|
Avital, Itzhak
|
CCR (NCI)
|
Total relevant funding to Digestive Diseases for this search: $465,474,914
|